New results from MIND-AD randomised controlled trial
The multinational MIND-ADmini trial demonstrated for the first time that a multidomain lifestyle intervention, alone or combined with medical food, is feasible and beneficial for persons with early (prodromal) Alzheimer’s disease. The intervention was safe, well-adhered, with the lifestyle+medical food group showing a reduced rate of cognitive-functional decline after 6 months. The study was recently […]
New results from MIND-AD randomised controlled trial Read More »